• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Tandem stock dives on Q3 misses, reduced guidance

November 2, 2022 By Sean Whooley

Tandem Diabetes Care tslim_X2_Insulin_Pump_Front_View_Control-IQ_RGB

Tandem Diabetes Care (Nasdaq:TNDM) shares took a big hit after hours on third-quarter results that missed the consensus forecast. Shares of TNDM. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.3%. The San Diego-based company posted losses of nearly $49 million for the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Fractyl Health forms task force to understand root causes of type 2 diabetes

November 2, 2022 By Sean Whooley

This is the logo of Fractyl Health.

Fractyl Health announced today that it created the Erase T2D task force to research type 2 diabetes in the hopes of “erasing” the condition. The academic-industry scientific partnership aims to advance research on the role of the gut in metabolic disease. This, in turn, could catalyze future discoveries on understanding and erasing type 2 diabetes. […]

Filed Under: Business/Financial News, Diabetes, Featured, Surgical Tagged With: Fractyl Health

Ascensia launches online diabetes management, analytics platform in U.S.

November 2, 2022 By Sean Whooley

Ascensia Diabetes Care GlucoContro diabetes management platform

Ascensia Diabetes Care announced today that it launched its online diabetes management and analytics platform in the U.S. Parsippany, New Jersey-based Ascensia now offers GlucoContro.online in more than 15 countries around the world. It plans for further expansion, too. GlucoContro.online supports diabetes management, according to a news release. It enables data-driven care for people using […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Ascensia Diabetes Care

Health Canada licenses Medtronic next-gen MiniMed 780G insulin pump

November 1, 2022 By Sean Whooley

Marketing image of Medtronic MiniMed 780G with Guardian

Medtronic (NYSE:MDT) Canada announced today that Health Canada granted a license to its MiniMed 780G automated insulin delivery system. The company designed its MiniMed 780G advanced hybrid closed-loop insulin pump system to automatically adjust and correct sugars every five minutes. According to Medtronic, it marks the first and only insulin pump system in Canada to […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Health Canada, Medtronic

Here’s what diabetes tech companies are doing for National Diabetes Awareness Month

November 1, 2022 By Sean Whooley

World Diabetes day

As we enter November, we enter National Diabetes Awareness Month. A number of diabetes technology developers plan to mark that in a special way. Dexcom (Nasdaq:DXCM), Insulet (Nasdaq:PODD) and Embecta (Nasdaq:EMBC) all announced their plans to celebrate. Last year, a handful of companies marked the month — which includes World Diabetes Day (Nov. 14) — […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Diabetes, embecta, Insulet

Enable Injections to add hundreds of jobs in Ohio

October 31, 2022 By Sean Whooley

enfuse-enable-injections

Enable Injections announced today that it committed to increasing jobs and payroll in the Cincinnati, Ohio region. The company intends to add 257 jobs and nearly $20 million in payroll in Cincinnati by 2027. Ohio’s Tax Credit Authority Board approved the commitment today. It allows the company to benefit from Ohio’s Job Creation Tax Credit […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Enable Injections

Dexcom stock rises on Q3 results following G7 international rollout

October 28, 2022 By Sean Whooley

Dexcom updated logo

Dexcom (Nasdaq:DXCM) shares are up today — a day after it reported third-quarter results that came in ahead of the consensus forecast. DXCM shares were up more than 17% at $118.78 by the afternoon today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down more than […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Abbott FreeStyle Libre named ‘best medical technology’ in last 50 years by Galien Foundation

October 28, 2022 By Sean Whooley

Abbott FreeStyle Libre 3 sensor pennies CGM diabetes

Abbott (NYSE:ABT) announced today that the Galien Foundation picked its FreeStyle Libre continuous glucose monitor (CGM) for a major award. The foundation named FreeStyle Libre as the best “Best Medical Technology” of the last 50 years. Other medtech receiving the designation included Edwards Lifesciences’ Sapien 3 Ultra TAVR and Roche’s Cobas HPV test. This announcement […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Galien Foundation

Kennesaw State researchers aim to improve glucose monitoring with non-invasive tech

October 27, 2022 By Sean Whooley

Kennesaw State researchers diabetes blood glucose

Kennesaw State University researchers developed a way to improve the glucose monitoring process for those living with diabetes. Maria Valero, an assistant professor of information technology at KSU’s College of Computing and Software Engineering (CCSE) and director of its IoT as a Service Research Group undertook the mission after watching her diabetic father use fingersticks […]

Filed Under: Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: blood glucose monitoring, Diabetes, glucose monitoring

Better Therapeutics names new chief commercial officer

October 27, 2022 By Sean Whooley

Better Therapeutics BT-001 diabetes digital therapeutic

Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Diane Gomez-Thinnes as its new chief commercial officer (CCO). Gomez-Thinnes’ appointment became effective yesterday, Oct. 26, 2022. She joins the San Francisco-based company, which develops prescription digital therapeutics (PDTs). They use a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: Better Therapeutics, Personnel Moves

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Interim pages omitted …
  • Page 168
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS